Research Design Service: West Midlands
« back

Target Ovarian Cancer: Translational Research Awards

  Friday, 28 May 2021 | Funding Deadline

Target Ovarian Cancer works to improve early diagnosis, fund life-saving research and provide much-needed support to everyone affected by ovarian cancer.

Translational Research Awards fund projects that will optimise and develop more effective and less toxic treatments for ovarian cancer, with a special focus on treatments that will improve overall survival. These awards aren't designed for basic or early discovery studies.

Some of the aims of the wards are:

  • Identify new drug targets within subtypes of ovarian cancer and develop new targeted treatments
  • Understand why tumours develop resistance to therapies, developing strategies to prevent and overcome resistance
  • Develop new immunologic approaches to treating ovarian cancer
  • Understand the effectiveness of existing drugs against different tumour subtypes
  • Understand the effectiveness of specific drug combinations in subtypes
  • Research to predict which patients will benefit from chemotherapy
  • Develop appropriate treatments for older patients
  • Identify prognostic markers that indicate response to treatment
  • Develop robust surgical trials to validate new technologies and optimise treatments


Deadline for proposals: 28th May 2021

Find out more here